However, activation of BRAF or NRAS is insufficient to promote melanoma initiation without senescence bypass mediated by additional founder mutations or expression changes of several genes including p16INK4A, CTNNB1, PTEN, or MDM43–7. This evidence concerns the gene NRAS and melanoma.